CORTEXYME Trademark

Trademark Overview


On Friday, December 11, 2015, a trademark application was filed for CORTEXYME with the United States Patent and Trademark Office. The USPTO has given the CORTEXYME trademark a serial number of 86847174. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 10, 2023. This trademark is owned by Cortexyme, Inc. The CORTEXYME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; medical research services in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultation
cortexyme

General Information


Serial Number86847174
Word MarkCORTEXYME
Filing DateFriday, December 11, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 10, 2023
Registration Number5007663
Registration DateTuesday, July 26, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements


Description of MarkThe mark consists of design of a human brain with an arrow and the block letter word "CORTEXYME" to the right.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical research; medical research services in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 10, 2023
Primary Code042
First Use Anywhere DateWednesday, October 23, 2013
First Use In Commerce DateWednesday, October 23, 2013

Trademark Owner History


Party NameQUINCE THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Party NameCortexyme, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCortexyme, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCortexyme, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Friday, February 10, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, October 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 12, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 12, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 26, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2016ASSIGNED TO EXAMINER
Friday, December 18, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 15, 2015NEW APPLICATION ENTERED